A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Researchers have been able to manipulate large chunks of genetic code for almost 50 years. But it is only within the past decade that they have been able to do it with exquisite precision – adding, ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Tardigrades are going under the knife. At least their genes are. A ...
Researchers at Gladstone Institutes (CA, USA) have mapped the human immune response using next-generation CRISPR technology known as base editing. Using this tool, the team was able to identify ...
Some species of tardigrades are highly and unusually resilient to various extreme conditions fatal to most other forms of life. The genetic basis for these exceptional abilities remains elusive.
Daily Express US on MSN
Jurassic Park-like endangered species could be saved by new blood test
A new blood-based cloning method from Colossal Biosciences is offering fresh hope for Jurassic Park -like endangered species.
Screen Rant on MSN
Colossal Biosciences Acquires Cloning Company Viagen: How It Advances De-Extinction and Conservation (Exclusive)
Colossal Biosciences expands its de-extinction mission by acquiring Viagen, the world leader in animal cloning and species ...
Over the past two decades, the immune system has attracted increasing attention for its role in fighting cancer. As researchers have learned more and more about the cancer-immune system interplay, ...
Case Western Reserve researcher finds new use for revolutionary gene-splicing tool; electrochemical platform could lead to blood test for HPV, parvo or others The gene-editing tool CRISPR has been ...
A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like Sickle Cell, while also proving beyond doubt that chemical tags on DNA — often ...
The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to new findings. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results